Introduction {#sec1-1}
============

Plasma cell neoplasms can be classified as multiple myeloma, solitary plasmacytomas of bone, and extramedullary plasmacytomas.\[[@ref1]\] Plasmacytomas can occur in soft-tissue lesions in soft tissue or bone.\[[@ref1]\] They are most commonly found in the axial skeleton (thoracic and lumbar spine).\[[@ref1]\] Skull vault plasmacytomas are rare lesions comprising 0.7% of all plasmacytomas.\[[@ref2][@ref3]\] They can mimic meningiomas, osteogenic sarcomas, or metastatic carcinomas on radiologic imaging.

Case Report {#sec1-2}
===========

A 63-year-old-female presented to us with a swelling over the vertex of the skull for the past 1 year which was insidious in onset, painless, of the size of a lemon when it was first noticed and gradually progressed to achieve the present size of about a cricket ball. The swelling was nontender on palpation and the overlying skin was normal. On examination, she was conscious oriented and had no neurological deficits. The progressively increasing scalp swelling made her seek medical attention. Noncontrast computed tomography (CT) head done showed a large extra-axial swelling of size 10.3 cm × 8 cm × 7 cm over midline (left \> right) frontoparietal parasagittal region causing compression of underlying brain and erosion of skull \[[Figure 1](#F1){ref-type="fig"}\]. Magnetic resonance imaging (MRI) brain \[[Figure 2](#F2){ref-type="fig"}\] revealed a large heterogeneously enhancing lesion over midline (left \> right) frontoparietal parasagittal region. On magnetic resonance venogram \[[Figure 3](#F3){ref-type="fig"}\], the middle part of the superior sagittal sinus was not visualized. Rest of the veins was normal. A provisional diagnosis of parasagittal meningioma was made. On digital subtraction angiography, tumor was fed by feeders from a bilateral superficial temporal artery, middle meningeal artery, and occipital artery. During embolization, dangerous anastomosis between anterior trunk of the middle meningeal artery and ophthalmic was carefully ruled out before all feeders were superselectively embolized using polyvinyl alcohol particles to achieve tumor devascularization. After embolization, the patient was planned for surgery after 5 days. The patient\'s head was fixed in three pins and positioned in a semi-sitting position. There was a large, gray white, soft-to-firm, moderately vascular, extradural tumor destroying the calvarium. No dural or sinus invasion was seen. The intraoperative impression was that of a tumor of bony origin. Histopathology \[[Figure 4](#F4){ref-type="fig"}\] revealed a tumor with sheets of plasmacytoid cells with large areas of necrosis and microabscesses. The cells were round to oval with moderate amounts of cytoplasm and eccentric nuclei. On immunohistochemistry, most cells were positive for CD138 and lambda light chain suggestive of a plasmacytoma. Serum light chain assay showed grossly elevated lambda light chain levels. On serum electrophoresis, M spike was not seen. Serum calcium levels and renal function were normal. Positron emission tomography (PET) scan revealed uptake in C3, C4, and C5 vertebra and left iliac bone establishing a final diagnosis of light chain myeloma. The patient was then referred to hematology-oncology department for bone marrow evaluation and adjuvant chemotherapy.

![(a) Noncontrast computed tomography head showing large hyperdense extra-axial lesion over midline frontoparietal region. (b) Noncontrast computed tomography head (bone window) showing erosion of the skull](AJNS-14-231-g001){#F1}

![(a) Magnetic resonance imaging showing an isointense tumor on T1-weighted sequence. (b) Magnetic resonance imaging axial view showing a hyperintense tumor on T2-weighted sequence. (c) Contrast-enhanced magnetic resonance imaging (coronal) showing heterogeneously enhancing tumor (with appearance suggestive of sulci and gyri: mini-brain appearance; see inset for illustration). (d) Contrast-enhanced magnetic resonance imaging (sagittal) showing heterogeneously enhancing tumor (with appearance suggestive of sulci and gyri: mini-brain appearance; see inset for illustration)](AJNS-14-231-g002){#F2}

![On magnetic resonance venogram, middle part of superior sagittal sinus was not visualized](AJNS-14-231-g003){#F3}

![(a) Low-power microscopy (H and E, ×20) showing a cellular tumor lying in sheets. Tumor is seen breaching the bone (arrow). (b) High-power microscopy (H and E, ×40) showing plasmacytoid cells with atypical and binucleate forms. (c) Immunohistochemistry showing diffuse positivity for lambda light chain and absence of kappa chain (light chain restriction)](AJNS-14-231-g004){#F4}

Discussion {#sec1-3}
==========

Myeloma is a hematological malignancy that originates from plasma cells of bone marrow.\[[@ref1][@ref2]\] Plasma cell neoplasms can be classified into multiple myeloma, solitary plasmacytomas of bone, and extramedullary plasmacytomas.\[[@ref1][@ref2]\] While multiple myeloma is a systemic disease, solitary plasmacytoma and extramedullary plasmacytomas are focal forms of plasma cell neoplasms. Plasmacytomas occur as mass lesions in soft tissue or bone. Skull vault plasmacytomas are very rare, comprising 0.7% of all plasmacytomas, most common locations being thoracic and lumbar spine.\[[@ref2][@ref3]\] As per our information, this is the first case report of a plasmacytoma in a parasagittal location which closely mimicked the appearance of a parasagittal meningioma.

In such cases, a differential diagnosis of meningioma, osteosarcoma, metastatic carcinoma, and plasmacytoma must be considered. We considered meningioma as the most likely possibility because of its common occurrence in the parasagittal location. For meningioma, it must be remembered that they rarely cause osteolysis albeit for intraosseous forms.\[[@ref4]\] Osteosarcomas occur mostly in long bones and rarely involve the skull when they cause the destruction of outer table and present as extracranial masses.\[[@ref2][@ref4]\] Osteolytic metastatic carcinoma is usually multiple and has punched out margins.\[[@ref4]\]

Plasmacytomas may be identified as osteolytic lesions on X-ray.\[[@ref2][@ref4][@ref5]\] On a CT scan, they are seen as osteolytic lesions without sclerotic rim and homogeneous contrast enhancement. They show variable intensity on T1-weighted images but enhance strongly on administration of gadolinium.\[[@ref4][@ref5]\] The sharp borders of the lesion, lack of sclerosis, and minimal periosteal reaction are strongly suggestive of a plasmacytoma. In our case, lesion was hyperintense, osteolytic without sclerosis on the CT scan. It was hyperintense on T1 and was heterogeneously contrast enhancing on MRI. On retrospective review, lesion was seen to have "mini-brain appearance." "Mini-brain appearance" was first described by Major *et al*. in their series of spinal plasmacytomas.\[[@ref1]\] As in our case, "mini-brain appearance" can be retrospectively seen in cases of calvarial plasmacytomas reported in the literature \[[Table 1](#T1){ref-type="table"}\]. We feel that finding this characteristic appearance can aid in forming a radiological diagnosis of a calvarial plasmacytomas even in locations where this lesion is extremely rare.

###### 

Reported cases of skull vault plasmacytoma with "mini-brain appearance"

  Serial number   Author                         Year   Age/sex     Location           Lesion size (mm)
  --------------- ------------------------------ ------ ----------- ------------------ ------------------
  1               Nagatomo *et al*.\[[@ref5]\]   1994   56/male     Temporo-parietal   60 × 40
  2               Matsuda *et al*.\[[@ref6]\]    1996   55/female   Fronto-temporal    70 × 50
  3               Okamoto *et al*.\[[@ref7]\]    1997   72/female   Occipital          NA
  4               Okamoto *et al*.\[[@ref7]\]    1997   64/male     Occipital          60 × 90
  5               Tanaka *et al*.\[[@ref3]\]     1998   55/male     Frontal            80 × 80
  6               Zigouris *et al*.\[[@ref8]\]   2009   78/female   Temporo-parietal   98 × 80
  7               Bakar and Tekkok\[[@ref4]\]    2010   49/male     Frontal            90 × 85
  8               Simoni *et al*.\[[@ref9]\]     2013   48/male     Frontal            60 × 35
  9               Present case                   2017   63/female   Fronto-parietal    103 × 80

NA - Not available

For embolization of tumors fed by the middle meningeal artery, overt and covert "dangerous anastomosis between anterior trunk of the middle meningeal artery and ophthalmic artery" must be ruled out during angiography and superselective distal embolization of tumor feeders must be done to avoid catastrophic complications.

Chemotherapy is the treatment of choice for multiple myeloma.\[[@ref2]\] Skull plasmacytomas are treated by excision followed by radiotherapy.\[[@ref6][@ref7]\] After a diagnosis of skull plasmacytoma, patients must be evaluated for myeloma using a battery of tests such as serum light chain assay, serum electrophoresis, urine for Bence--Jones protein, PET scan, and bone marrow examination.\[[@ref9]\] The monoclonal nature of tumor cells must also be confirmed to rule out the possibility of plasma cell granuloma. The prognosis of solitary plasmacytomas and extramedullary plasmacytomas is better as compared to that of multiple myeloma.\[[@ref7][@ref8]\] These patients must be followed up closely to detect progression to multiple myeloma.

Conclusion {#sec1-4}
==========

Skull vault plasmacytomas are rare lesions. Their appearance can often mimic other skull vault lesions such as meningioma, osteosarcoma, and metastatic carcinoma. Findings of "mini-brain appearance" can help in the formation of diagnosis in such cases.
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